Tandem Diabetes Care Inc (TNDM)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.40B
Last updated: Nov 17, 2026 at 4:15 PM ET
Tandem Diabetes Care Inc (TNDM) Stock Chart
Tandem Diabetes Care (TNDM) has a latest price of $17.06 on Nov 17, 2026, 42.5% below its 52-week high of $29.65. Its price fell 8.3% over the past 12 months. The month-end price fell 68.4% over the 10 years through Oct 2026, a compound annual decline of 10.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $150.52 in Dec 2021 and its lowest $2.36 in Dec 2017, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TNDM with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TNDM.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 27.3%, and over 6 months it rose 23.1%. The month-end price rose 10.5% over the 3 years through Oct 2026, a compound annual rate of 3.4%.
| Period | Change |
|---|---|
| 1 month | +4.2% |
| 3 months | -27.3% |
| 6 months | +23.1% |
| 12 months | -8.3% |
| 12 months, with dividends | -8.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +10.5% | +3.4% |
| 5 years | -86.0% | -32.5% |
| 10 years | -68.4% | -10.9% |
Price by Year
Its best calendar year was 2018, when the price rose 1,508.9%, and its weakest was 2017, when it fell 89.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $19.11 | -13.1% |
| 2025 | $21.98 | -39.0% |
| 2024 | $36.02 | +21.8% |
| 2023 | $29.58 | -34.2% |
| 2022 | $44.95 | -70.1% |
| 2021 | $150.52 | +57.3% |
| 2020 | $95.68 | +60.5% |
| 2019 | $59.61 | +57.0% |
| 2018 | $37.97 | +1,508.9% |
| 2017 | $2.36 | -89.0% |
Trading Range
The price is 1.5% below its 50-day average of $17.31 and 9.3% below its 200-day average of $18.82.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $17.06 | |
| 52-week high | $29.65 | -42.5% |
| 52-week low | $12.26 | +39.2% |
| 50-day average | $17.31 | -1.5% |
| 200-day average | $18.82 | -9.3% |
Price Risk
Over 3 years, its largest fall from a peak was 81.1%.
| Measure | Value |
|---|---|
| 1-year beta | 1.19 |
| Largest fall, 1 year | -54.6% |
| Largest fall, 3 years | -81.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TNDM
What is TNDM's 1-year price change?
Tandem Diabetes Care's price fell 8.3% over the past 12 months. With dividends included, the 12-month total return was -8.3%.
What is TNDM's 5-year price change?
Tandem Diabetes Care's month-end price fell 86.0% over the 5 years through Oct 2026, a compound annual decline of 32.5%. These figures leave out dividends.
What is TNDM's 52-week high and low?
Tandem Diabetes Care's 52-week high is $29.65 and its 52-week low is $12.26. Its latest price of $17.06 on Nov 17, 2026 is 42.5% below the high.
What is TNDM's beta?
Tandem Diabetes Care's 1-year beta against the S&P 500 is 1.19, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 54.6%.
Is the TNDM chart free?
Yes. Advanced Charting for TNDM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TNDM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors